Alinter Group News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Alinter Group. Real-time updates on events, politics, business and more.

Global IV & Oral Iron Drugs Market Report 2024: Market to Reach $16.43 Billion by 2029 with CSL Vifor, Covis Pharmaceuticals, Daiichi Sankyo, Akebia Therapeutics, Shield Therapeutics Dominating

February 10, 2024

/PRNewswire/ -- The "Global IV & Oral Iron Drugs Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.coms offering. The global IV...

United States Vifor Pharma Laura Wood Zydus Lifesciences Daiichi Sankyo Office Hours Call

Source: prnewswire.com

Global IV & Oral Iron Drugs Market Report 2024: Focused

February 9, 2024

Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The

United States Vifor Pharma Zydus Lifesciences Daiichi Sankyo Covis Pharmaceuticals Patient Group

Source: globenewswire.com

The Global IV and Oral Iron Drugs Market Sees Explosive Growth, the Market to Reach $16.34 Billion by 2029

January 23, 2024

/PRNewswire/ -- According to Ariztons latest research report, the global IV and Oral Iron Drugs market is growing at a CAGR of 13.47% during 2023-2029. To...

South Africa Saudi Arabia United States Zydus Lifesciences Vifor Pharma Daiichi Sankyo

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Alinter Group News Today

Global IV & Oral Iron Drugs Market Report 2024: Market to Reach $16.43 Billion by 2029 with CSL Vifor, Covis Pharmaceuticals, Daiichi Sankyo, Akebia Therapeutics, Shield Therapeutics Dominating

Global IV & Oral Iron Drugs Market Report 2024: Focused

The Global IV and Oral Iron Drugs Market Sees Explosive Growth, the Market to Reach $16.34 Billion by 2029

Explore More Categories